Support from readers like you keeps The Journal open.
You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.
If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.
INDEPENDENT POLITICIAN LUKE ‘Ming’ Flanagan is currently dotting the i’s and crossing the t’s on a bill that will propose the legalisation of cannabis in Ireland.
Flanagan’s bill, which is due to be launched in the coming days, is expected to include provisions for people to both purchase the drug and grow cannabis plants themselves.
Opponents to the legalisation have warned that it could result in more people using the drug, saying it can also be a gateway substance and may increase the use of other more harmful drugs.
However others in favour of it have said that regulating could lower the risks of people using contaminated drugs, reduce crime and yield a high tax revenue.
So where do the various political parties, technical groups and independent TDs stand on the issue? We decided to ask them.
FINE GAEL
(Image: Mark Stedman/Photocall Ireland)
As Fine Gael health spokesperson, Minister for Health James Reilly was nominated by his party to answer for them. His department pointed out that, under the Misuse of Drugs Act, 1977, the manufacture, production, preparation, sale, supply, distribution and possession of cannabis or cannabis-based medicinal products are unlawful except for the purposes of research. Cannabis is also controlled internationally under United Nations Conventions.
It is not the intention of Government to legalise the use of cannabis either for medical or recreational reasons, owing to a number of concerns, including its potential for abuse and concern for public health. Cannabis misuse is detrimental to health and significant physical and mental health risks are particularly associated with long-term use. Legalising cannabis may lead to increased levels of experimentation with drugs by young people.
The legalisation of cannabis in Ireland cannot be considered in isolation of the other EU Member States as this could result in Ireland becoming a destination for “drug tourism” with consequential social problems.
It is internationally recognised that leniency in cannabis control can endanger the overall international effort against drugs. The Government’s position regarding controls on cannabis is in line with United Nations Conventions and international law on the control of cannabis.
A cannabis-based drug called Sativex has recently been identified as being suitable for the relief of symptoms of spasticity for people with Multiple Sclerosis (MS). Sativex is currently aurhorised in the UK for MS patients and the Irish Medicines Board has recommended the approval of the product for the Irish market.
However the department said that the granting of market authorisation in Ireland is dependent on changes to legislation.
Department officials have been engaging with experts on how best to legally describe authorised cannabis-based medicinal products while maintaining existing controls on cannabis and cannabis substances.
Draft Regulations amending the Misuse of Drugs Regulations have been prepared, including amendments necessary to enable cannabis-based medicinal product Sativex to be prescribed in Ireland. Arising from the consultation process, the draft orders and Misuse of Drugs (Amendment) Regulations will be submitted to government seeking the government’s approval to notify them to the EU Commission and Member States under the Technical Standards Directive.
At the end of the three month EU notification period, government’s approval will be sought to make the relevant order. The department said it is anticipated that the new regulations will be introduced early next year.
LABOUR
(Image: Sam Boal/Photocall Ireland)
A spokesperson for Labour said the party was not in favour of full legalisation but declined to give a reason. However they mirrored the department’s comments on a change in legislation to allow for the availability of Sativex.
I understand from Minister of State at the Department of Health, Minister Alex White, that the Department of Health has been informed by the Irish Medicines Board that it is currently in receipt of a market authorisation request in relation to a medicinal product containing cannabis extract which is used for the treatment of people with multiple sclerosis. The department is currently engaging with experts to identify how best to proceed in terms of cannabis-based medicinal products and I understand that legislative proposals will be brought forward in coming months.
FIANNA FÁIL
Advertisement
(Image: Julien Behal/PA)
A spokesperson for the party said:
The party position is that we support legalisation for medical purposes but not in any other circumstances. We don’t believe there is a strong enough body of evidence to warrant further legislation. We are not convinced that legalising cannabis would not cause further difficulty as there is still very strong evidence that it is a gateway drug and leads to people becoming addicted to stronger drugs.
SINN FÉIN
(Image: Niall Carson/PA)
Sinn Féin also opposes the legalisation of cannabis, according to a party spokesperson.
With reference to cannabis for medicinal use, this is a matter which would require a full Health Technology Assessment for clinical effectiveness by the relevant expert agencies. We await the findings of such an assessment before commenting further.
THE SOCIALIST PARTY
(Image: Sasko Lazarov/Photocall Ireland)
A party spokesperson told TheJournal.ie:
The Socialist Party supports legalisation of cannabis but it should be made available through a State monopoly with accompanying safeguards for harm minimisation and education about the effects of use. We are opposed to the criminalisation of young people and we believe that it is a waste of garda resources.
JOAN COLLINS (People Before Profit)
(Image: Sam Boal/Photocall Ireland)
While Collins said this was not something she had discussed with her colleagues, either in People Before Profit or the ULA Dáil technical group, her own position is that she is in favour of decriminalisation.
I think it’s madness that people with a small amount of cannabis, for their own use, can get hauled in and harrassed by gardaí that have bigger things to do. Decriminalisation takes it out of that bracket and focuses the resources in the people who are really in charge – the guards know who they are so they should put their resources into that.
I’m not 100 per cent on it [full legalisation], I’d want to talk to people in the community to get their response because they’re the ones dealing with drug use. My opinion would be directed by them really and what their view would be about how it would impact on the community.
As for legalising it for medical purposes:
I think there’s a very strong argument for that, I’ve seen material in relation to Alzheimers and MS and I think that should be brought through the medical procedures, with pharmacists involved in it. All of the evidence seems to be that it does assist people so I’d certainly be very open to that. I think like everything there should be studies done and if it’s proven that it can help then why not? It makes sense to me anyway, for it to be available in a controlled environment, obviously on the basis of a patient-doctor relationship. I think there’s no harm in debating these things, getting opinions from people ans services that deal with it every day of the week. It can help to revisit it because what was suitable five years ago might not be now.
LUCINDA CREIGHTON (The Reform Alliance)
(Image: Laura Hutton)
TheJournal.ie spoke to former Fine Gael TD Luncina Creighton, who said it was not an issue the newly formed technical group had discussed. Her own personal opinion is as follows:
I’d be skeptical, I think I haven’t seen any compelling evidence to support the idea of legalisation. There is some evidence to suggest it can lead to worse addictions to other circumstances. When you think about how much we are spending waging the war on tobacco, if we legalise something else that can be addictive, it’s a big business and if people growing cannabis have the intention of growing the market and generating more addiction then I’m not really sure that adds up either.
We’ll see, maybe Ming has some revelation he’s share with us and that will change things.
I think obviously where people have serious health issues and conditions, whether they’re life threatening or completely debilitating, if there is some genuine medicinal value then it’s worth considering. That really depends on expert advice, people who can guide us in that area. All legislators can do is base advice on best practice, I certainly wouldn’t rule it out but I don’t have enough medical expertise myself.
A number of other independent TDs were asked to contribute their opinions but we received no reply from them by the time of publication.
Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article.
Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.
JD Vance says US take over of Greenland ‘makes sense’ during scaled back visit
Updated
1 hr ago
30.7k
95
arctic reception
JD Vance says US take over of Greenland ‘makes sense’ during scaled back visit
Updated
1 hr ago
30.7k
95
Your Cookies. Your Choice.
Cookies help provide our news service while also enabling the advertising needed to fund this work.
We categorise cookies as Necessary, Performance (used to analyse the site performance) and Targeting (used to target advertising which helps us keep this service free).
We and our 160 partners store and access personal data, like browsing data or unique identifiers, on your device. Selecting Accept All enables tracking technologies to support the purposes shown under we and our partners process data to provide. If trackers are disabled, some content and ads you see may not be as relevant to you. You can resurface this menu to change your choices or withdraw consent at any time by clicking the Cookie Preferences link on the bottom of the webpage .Your choices will have effect within our Website. For more details, refer to our Privacy Policy.
We and our vendors process data for the following purposes:
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised advertising and content, advertising and content measurement, audience research and services development.
Cookies Preference Centre
We process your data to deliver content or advertisements and measure the delivery of such content or advertisements to extract insights about our website. We share this information with our partners on the basis of consent. You may exercise your right to consent, based on a specific purpose below or at a partner level in the link under each purpose. Some vendors may process your data based on their legitimate interests, which does not require your consent. You cannot object to tracking technologies placed to ensure security, prevent fraud, fix errors, or deliver and present advertising and content, and precise geolocation data and active scanning of device characteristics for identification may be used to support this purpose. This exception does not apply to targeted advertising. These choices will be signaled to our vendors participating in the Transparency and Consent Framework.
Manage Consent Preferences
Necessary Cookies
Always Active
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then these services may not function properly.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not be able to monitor our performance.
Store and/or access information on a device 110 partners can use this purpose
Cookies, device or similar online identifiers (e.g. login-based identifiers, randomly assigned identifiers, network based identifiers) together with other information (e.g. browser type and information, language, screen size, supported technologies etc.) can be stored or read on your device to recognise it each time it connects to an app or to a website, for one or several of the purposes presented here.
Personalised advertising and content, advertising and content measurement, audience research and services development 142 partners can use this purpose
Use limited data to select advertising 112 partners can use this purpose
Advertising presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type or which content you are (or have been) interacting with (for example, to limit the number of times an ad is presented to you).
Create profiles for personalised advertising 83 partners can use this purpose
Information about your activity on this service (such as forms you submit, content you look at) can be stored and combined with other information about you (for example, information from your previous activity on this service and other websites or apps) or similar users. This is then used to build or improve a profile about you (that might include possible interests and personal aspects). Your profile can be used (also later) to present advertising that appears more relevant based on your possible interests by this and other entities.
Use profiles to select personalised advertising 83 partners can use this purpose
Advertising presented to you on this service can be based on your advertising profiles, which can reflect your activity on this service or other websites or apps (like the forms you submit, content you look at), possible interests and personal aspects.
Create profiles to personalise content 38 partners can use this purpose
Information about your activity on this service (for instance, forms you submit, non-advertising content you look at) can be stored and combined with other information about you (such as your previous activity on this service or other websites or apps) or similar users. This is then used to build or improve a profile about you (which might for example include possible interests and personal aspects). Your profile can be used (also later) to present content that appears more relevant based on your possible interests, such as by adapting the order in which content is shown to you, so that it is even easier for you to find content that matches your interests.
Use profiles to select personalised content 34 partners can use this purpose
Content presented to you on this service can be based on your content personalisation profiles, which can reflect your activity on this or other services (for instance, the forms you submit, content you look at), possible interests and personal aspects. This can for example be used to adapt the order in which content is shown to you, so that it is even easier for you to find (non-advertising) content that matches your interests.
Measure advertising performance 133 partners can use this purpose
Information regarding which advertising is presented to you and how you interact with it can be used to determine how well an advert has worked for you or other users and whether the goals of the advertising were reached. For instance, whether you saw an ad, whether you clicked on it, whether it led you to buy a product or visit a website, etc. This is very helpful to understand the relevance of advertising campaigns.
Measure content performance 59 partners can use this purpose
Information regarding which content is presented to you and how you interact with it can be used to determine whether the (non-advertising) content e.g. reached its intended audience and matched your interests. For instance, whether you read an article, watch a video, listen to a podcast or look at a product description, how long you spent on this service and the web pages you visit etc. This is very helpful to understand the relevance of (non-advertising) content that is shown to you.
Understand audiences through statistics or combinations of data from different sources 74 partners can use this purpose
Reports can be generated based on the combination of data sets (like user profiles, statistics, market research, analytics data) regarding your interactions and those of other users with advertising or (non-advertising) content to identify common characteristics (for instance, to determine which target audiences are more receptive to an ad campaign or to certain contents).
Develop and improve services 83 partners can use this purpose
Information about your activity on this service, such as your interaction with ads or content, can be very helpful to improve products and services and to build new products and services based on user interactions, the type of audience, etc. This specific purpose does not include the development or improvement of user profiles and identifiers.
Use limited data to select content 37 partners can use this purpose
Content presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type, or which content you are (or have been) interacting with (for example, to limit the number of times a video or an article is presented to you).
Use precise geolocation data 46 partners can use this special feature
With your acceptance, your precise location (within a radius of less than 500 metres) may be used in support of the purposes explained in this notice.
Actively scan device characteristics for identification 27 partners can use this special feature
With your acceptance, certain characteristics specific to your device might be requested and used to distinguish it from other devices (such as the installed fonts or plugins, the resolution of your screen) in support of the purposes explained in this notice.
Ensure security, prevent and detect fraud, and fix errors 92 partners can use this special purpose
Always Active
Your data can be used to monitor for and prevent unusual and possibly fraudulent activity (for example, regarding advertising, ad clicks by bots), and ensure systems and processes work properly and securely. It can also be used to correct any problems you, the publisher or the advertiser may encounter in the delivery of content and ads and in your interaction with them.
Deliver and present advertising and content 99 partners can use this special purpose
Always Active
Certain information (like an IP address or device capabilities) is used to ensure the technical compatibility of the content or advertising, and to facilitate the transmission of the content or ad to your device.
Match and combine data from other data sources 72 partners can use this feature
Always Active
Information about your activity on this service may be matched and combined with other information relating to you and originating from various sources (for instance your activity on a separate online service, your use of a loyalty card in-store, or your answers to a survey), in support of the purposes explained in this notice.
Link different devices 53 partners can use this feature
Always Active
In support of the purposes explained in this notice, your device might be considered as likely linked to other devices that belong to you or your household (for instance because you are logged in to the same service on both your phone and your computer, or because you may use the same Internet connection on both devices).
Identify devices based on information transmitted automatically 88 partners can use this feature
Always Active
Your device might be distinguished from other devices based on information it automatically sends when accessing the Internet (for instance, the IP address of your Internet connection or the type of browser you are using) in support of the purposes exposed in this notice.
Save and communicate privacy choices 69 partners can use this special purpose
Always Active
The choices you make regarding the purposes and entities listed in this notice are saved and made available to those entities in the form of digital signals (such as a string of characters). This is necessary in order to enable both this service and those entities to respect such choices.
have your say